KIMBERLY STILLWACHS: Open Payments
NPI 1770947004 · SYLVA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 20 payments from 11 companies in 2025. Trend: 2023 $261 · 2024 $364 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $77 |
| Novo Nordisk Inc | 3 | $58 |
| Indivior Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Exact Sciences Corporation | 2 | $39 |
| Amgen Inc. | 2 | $32 |
| PFIZER INC. | 2 | $31 |
| Abbott Laboratories | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $20 |
Products named: Ozempic, VRAYLAR, SUBLOCADE, CAPLYTA, Cologuard Collection Kit, PREVNAR 20, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across NC — which companies pay providers there.
